Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluating gemcitabine plus cisplatin or a high-dose methotrexate/vinblastine/doxorubicin/cisplatin regimen for urothelial cancer ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Renal Pelvis Cancer
• Transitional Cell Carcinoma of the Bladder
• Ureter Cancer
• Urethral Cancer
• Urothelial Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOXORUBICIN HYDROCHLORIDE (Doxorubicin hydrochloride)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• METHOTREXATE (METHOTREXATE)
• Vinblastine (vinblastine)

Snippet

Sponsor: University of Southern California | Conditions: Anterior Urethral Cancer, Localized Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: WITHDRAWN